NCT05106296 2026-01-09Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerAugusta UniversityPhase 1 Recruiting37 enrolled
NCT02502708 2020-06-04Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain TumorsLumos PharmaPhase 1 Completed81 enrolled